Role for Furin in Tumor Necrosis Factor Alpha-Induced Activation of the Matrix Metalloproteinase/Sphingolipid Mitogenic Pathway

REFERENCES

• Adam, D., K. Wiegmann, S. Adam-Klages, A. Ruff, and M. Kronke. 1996. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271:14617–14622.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745–756.
   PubMed Web of Science ®Google Scholar
• Aubin, I., C. P. Adams, S. Opsahl, D. Septier, C. E. Bishop, N. Auge, R. Salvayre, A. Negre-Salvayre, M. Goldberg, J. L. Guenet, and C. Poirier. 2005. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat. Genet. 37:803–805.
   PubMed Web of Science ®Google Scholar
• Auge, N., N. Andrieu, A. Negre-Salvayre, J. C. Thiers, T. Levade, and R. Salvayre. 1996. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271:19251–19255.
   PubMedGoogle Scholar
• Auge, N., F. Maupas-Schwalm, M. Elbaz, J. C. Thiers, A. Waysbort, S. Itohara, H. W. Krell, R. Salvayre, and A. Negre-Salvayre. 2004. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110:571–578.
   PubMed Web of Science ®Google Scholar
• Auge, N., A. Negre-Salvayre, R. Salvayre, and T. Levade. 2000. Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog. Lipid Res. 39:207–229.
   PubMedGoogle Scholar
• Auge, N., M. Nikolova-Karakashian, S. Carpentier, S. Parthasarathy, A. Negre-Salvayre, R. Salvayre, A. H. Merrill, Jr., and T. Levade. 1999. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J. Biol. Chem. 274:21533–21538.
   PubMedGoogle Scholar
• Belien, A. T., P. A. Paganetti, and M. E. Schwab. 1999. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144:373–384.
   PubMed Web of Science ®Google Scholar
• Bolick, D. T., S. Srinivasan, K. W. Kim, M. E. Hatley, J. J. Clemens, A. Whetzel, N. Ferger, T. L. Macdonald, M. D. Davis, P. S. Tao, K. R. Lynch, and C. C. Hedrick. 2005. Sphingosine-1-phosphate prevents tumor necrosis factor-α-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 25:976–981.
   PubMed Web of Science ®Google Scholar
• Bornstein, P., A. Agah, and T. R. Kyriakides. 2004. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell. Biol. 36:1115–1125.
   PubMed Web of Science ®Google Scholar
• Canault, M., F. Peiretti, C. Mueller, F. Kopp, P. Morange, S. Rihs, H. Portugal, I. Juhan-Vague, and G. Nalbone. 2004. Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis 172:211–218.
   PubMed Web of Science ®Google Scholar
• Cao, J., P. Kozarekar, M. Pavlaki, C. Chiarelli, W. F. Bahou, and S. Zucker. 2004. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J. Biol. Chem. 279:14129–14139.
   PubMed Web of Science ®Google Scholar
• Deryugina, E. I., B. Ratnikov, E. Monosov, T. I. Postnova, R. DiScipio, J. W. Smith, and A. Y. Strongin. 2001. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263:209–223.
   PubMed Web of Science ®Google Scholar
• Dinter, A., and E. G. Berger. 1998. Golgi-disturbing agents. Histochem. Cell Biol. 109:571–590.
   PubMed Web of Science ®Google Scholar
• Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161–174.
   PubMed Web of Science ®Google Scholar
• Feliciangeli, S. F., L. Thomas, G. K. Scott, E. Subbian, C. H. Hung, S. S. Molloy, F. Jean, U. Shinde, and G. Thomas. 2006. Identification of a pH sensor in the furin propeptide that regulates enzyme activation. J. Biol. Chem. 281:16108–16116.
   PubMedGoogle Scholar
• Filippov, S., G. C. Koenig, T. H. Chun, K. B. Hotary, I. Ota, T. H. Bugge, J. D. Roberts, W. P. Fay, H. Birkedal-Hansen, K. Holmbeck, F. Sabeh, E. D. Allen, and S. J. Weiss. 2005. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J. Exp. Med. 202:663–671.
   PubMed Web of Science ®Google Scholar
• Fillmore, H. L., T. E. VanMeter, and W. C. Broaddus. 2001. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J. Neurooncol. 53:187–202.
   PubMed Web of Science ®Google Scholar
• Futerman, A. H., and Y. A. Hannun. 2004. The complex life of simple phospholipids. EMBO Rep. 5:777–782.
   PubMed Web of Science ®Google Scholar
• Gaur, U., and B. B. Aggarwal. 2003. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 66:1403–1408.
   PubMed Web of Science ®Google Scholar
• Goetze, S., U. Kintscher, K. Kaneshiro, W. P. Meehan, A. Collins, E. Fleck, W. A. Hsueh, and R. E. Law. 2001. TNF induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159:93–101.
   PubMed Web of Science ®Google Scholar
• Goni, F. M., and A. Alonso. 2002. Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531:38–46.
   PubMed Web of Science ®Google Scholar
• Hannun, Y. A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science 274:1855–1859.
   PubMed Web of Science ®Google Scholar
• Hiraoka, E., S. Kawashima, T. Takahashi, Y. Rikitake, T. Kitamura, W. Ogawa, and M. Yokoyama. 2001. TNF-alpha induces protein synthesis through PI3-kinase-Akt/PKB pathway in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 280:H1861–H1868.
   PubMedGoogle Scholar
• Ikeda, U., and K. Shimada. 2003. Matrix metalloproteinases and coronary artery diseases. Clin. Cardiol. 26:55–59.
   PubMed Web of Science ®Google Scholar
• Itoh, T., T. Ikeda, H. Gomi, S. Nakao, T. Suzuki, and S. Itohara. 1997. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272:22389–22392.
   PubMed Web of Science ®Google Scholar
• Kolesnick, R. 1994. Signal transduction through the sphingomyelin pathway. Mol. Chem. Neuropathol. 21:287–297.
   PubMedGoogle Scholar
• Kronke, M. 1999. Involvement of sphingomyelinases in TNF signaling pathways. Chem. Phys. Lipids 102:157–166.
   PubMedGoogle Scholar
• Lehti, K., J. Lohi, M. M. Juntunen, D. Pei, and J. Keski-Oja. 2002. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J. Biol. Chem. 277:8440–8448.
   PubMed Web of Science ®Google Scholar
• Liu, B., N. Andrieu-Abadie, T. Levade, P. Zhang, L. M. Obeid, and Y. A. Hannun. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 273:11313–11320.
   PubMed Web of Science ®Google Scholar
• Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501.
   PubMed Web of Science ®Google Scholar
• Marchesini, N., W. Osta, J. Bielawski, C. Luberto, L. M. Obeid, and Y. A. Hannun. 2004. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells. J. Biol. Chem. 279:25101–25111.
   PubMedGoogle Scholar
• Maupas-Schwalm, F., N. Auge, C. Robinet, J. P. Cambus, S. J. Parsons, R. Salvayre, and A. Negre-Salvayre. 2004. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J. 18:1398–1400.
   PubMedGoogle Scholar
• Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Netzel-Arnett, S., S. K. Mallya, H. Nagase, H. Birkedal-Hansen, and H. E. Van Wart. 1991. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal. Biochem. 195:86–92.
   PubMed Web of Science ®Google Scholar
• Newby, A. C., and A. B. Zaltsman. 1999. Fibrous cap formation or destruction—the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41:345–360.
   PubMed Web of Science ®Google Scholar
• Newby, A. C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85:1–31.
   PubMed Web of Science ®Google Scholar
• Pei, D., and S. J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:9135–9140.
   PubMed Web of Science ®Google Scholar
• Pena, L. A., Z. Fuks, and R. Kolesnick. 1997. Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol. 53:615–621.
   PubMed Web of Science ®Google Scholar
• Pettus, B. J., C. E. Chalfant, and Y. A. Hannun. 2002. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585:114–125.
   PubMed Web of Science ®Google Scholar
• Remacle, A. G., D. V. Rozanov, M. Fugere, R. Day, and A. Y. Strongin. 2006. Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP. Oncogene 25:5648–5655.
   PubMed Web of Science ®Google Scholar
• Rozanov, D. V., E. I. Deryugina, B. I. Ratnikov, E. Z. Monosov, G. N. Marchenko, J. P. Quigley, and A. Y. Strongin. 2001. Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J. Biol. Chem. 276:25705–25714.
   PubMedGoogle Scholar
• Sack, M. 2002. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol. Ther. 94:123–135.
   PubMed Web of Science ®Google Scholar
• Sato, T., T. Kondo, T. Fujisawa, M. Seiki, and A. Ito. 1999. Furin-independent pathway of membrane type 1-matrix metalloproteinase activation in rabbit dermal fibroblasts. J. Biol. Chem. 274:37280–37284.
   PubMedGoogle Scholar
• Singh, I., K. Pahan, M. Khan, and A. K. Singh. 1998. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273:20354–20362.
   PubMed Web of Science ®Google Scholar
• Spiegel, S., and S. Milstein. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol. 4:397–407.
   PubMed Web of Science ®Google Scholar
• Stoffel, W., B. Jenke, B. Block, M. Zumbansen, and J. Koebke. 2005. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl. Acad. Sci. USA 102:4554–4559.
   PubMed Web of Science ®Google Scholar
• Strongin, A. Y., I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G. I. Goldberg. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:5331–5338.
   PubMed Web of Science ®Google Scholar
• Suh, S. J., U. H. Jin, S. H. Kim, H. W. Chang, J. K. Son, S. H. Lee, K. H. Son, and C. H. Kim. 2006. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9. J. Cell Biochem. 99:1298–1307.
   PubMed Web of Science ®Google Scholar
• Tani, M., Y. Igarashi, and M. Ito. 2005. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu. J. Biol. Chem. 280:36592–36600.
   PubMedGoogle Scholar
• Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell. Biol. 3:753–766.
   PubMed Web of Science ®Google Scholar
• Varfolomeev, E. E., and A. Ashkenazi. 2004. Tumor necrosis factor: an apoptosis JuNKie? Cell 116:491–497.
   PubMed Web of Science ®Google Scholar
• Visse, R., and H. Nagase. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827–839.
   PubMed Web of Science ®Google Scholar
• Wang, Z., P. J. Rao, M. R. Castresana, and W. H. Newman. 2005. TNF-alpha induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype. Am. J. Physiol. Heart Circ. Physiol. 288:H293–301.
   PubMedGoogle Scholar
• Watanabe, M., A. Hirano, S. Stenglein, J. Nelson, G. Thomas, and T. C. Wong. 1995. Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J. Virol. 69:3206–3210.
   PubMedGoogle Scholar
• Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005–1015.
   PubMed Web of Science ®Google Scholar
• Xia, P., L. Wang, J. R. Gamble, and M. A. Vadas. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274:34499–34505.
   PubMed Web of Science ®Google Scholar
• Yana, I., and S. J. Weiss. 2000. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell 11:2387–2401.
   PubMed Web of Science ®Google Scholar
• Zucker, S., M. Hymowitz, C. E. Conner, E. A. DiYanni, and J. Cao. 2002. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Lab. Investig. 82:1673–1684.
   PubMedGoogle Scholar